Anna Oroń, PhD, is a clinical research leader with over 17 years of experience in the clinical trial industry, scientific research, and academic teaching. Currently serving as the Director of Clinical Trial Safety in Oncology at AstraZeneca, they lead safety oversight for global oncological trials while co-managing a team of over 90 employees. Anna holds a PhD in biology (neuroscience) and has a strong background in psychology, clinical operations, and cross-functional leadership. They have also contributed as an external lecturer at various universities, sharing knowledge in neuropsychology and neurorehabilitation.
This person is not in the org chart
This person is not in any teams
This person is not in any offices